Qlik, (NASDAQ: QLIK), a leader in user-driven Business Intelligence (BI), today announced that it has been named “Best in KLAS” in the 2013 Best in KLAS: Software and Services report. KLAS is a research firm specializing in monitoring and reporting healthcare vendor performance. This award, which celebrates vendors receiving the highest provider scores in their market segments based on data collected and verified throughout 2013, comes just one month following the organization’s number one ranking in the KLAS report “Healthcare Analytics: Making Sense of the Puzzle Pieces.”
With an overall score of 85.6, Qlik was the top rated vendor within the business intelligence/analytics market segment in the 2013 Best in KLAS report and scored above the market average in all categories. This includes top rankings in sales and contracting, implementation and training, functionality and upgrades, as well as services and support. Qlik received a higher score than vendors such as Dimensional Insight and IBM Cognos to secure the number one ranking.
The 2013 Best in KLAS report ranks the best-performing healthcare IT vendors for more than 100 market segments based on healthcare provider feedback from the past year. In the 2013 report more than 16,000 healthcare providers shared their software and services vendor performance experiences with KLAS. The goal of the research is to enable providers to make more-informed technology decisions and help vendors strive for excellence.
“We are thrilled to be named Best in KLAS for 2013 among the business intelligence/analytics market segment,” said Lars Björk, Chief Executive Officer of Qlik. “We believe this is a testament to the value our solution provides healthcare organizations as well as our dedication to supporting the success of our customers. In an industry where improved insights can actually save lives, our customers are making discoveries that help them improve care, lower costs, and drive efficiency in all areas of their organizations.”
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts